Evidence map›Paper›PMID 16498158›Full record

Trial reportEmergency medicine journal : EMJ2006

Is atropine needed with ketamine sedation? A prospective, randomised, double blind study.

P Heinz, G C Geelhoed, C Wee, E M Pascoe

Open access · greenAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Emergency medicine journal : EMJ, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Efficacy and safety of ketamine in mechanically ventilated intensive care unit patients: a scoping review.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2022
    Article
  10. Observational
  11. Article
  12. Article
  13. Ketamine Sedation in Gastrointestinal Endoscopy in Children.Open access Macedonian journal of medical sciences · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Sedoanalgesia in pediatric daily surgery.International journal of clinical and experimental medicine · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P HeinzDepartment of Paediatrics, Addenbrooke's Hospital, Cambridge University Hospital Foundation Trust, Cambridge, UK. Peter.Heinz@addenbrookes.nhs.uk
G C Geelhoed
C Wee
E M Pascoe
Addenbrooke's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare atropine with placebo as an adjunct to ketamine sedation in children undergoing minor painful procedures. Outcome measures included hypersalivation, side effect profile, parental/patient satisfaction, and procedural success rate.

methodsChildren aged between 1 and 16 years of age requiring ketamine procedural sedation in a tertiary emergency department were randomised to receive 0.01 mg/kg of atropine or placebo. All received 4 mg/kg of intramuscular ketamine. Tolerance and sedation scores were recorded throughout the procedure. Side effects were recorded from the start of sedation until discharge. Parental and patient satisfaction scores were obtained at discharge and three to five days after the procedure, with the opportunity to report side effects encountered at home.

resultsA total of 83 patients aged 13 months to 14.5 years (median age 3.4 years) were enrolled over a 16 month period. Hypersalivation occurred in 11.4% of patients given atropine compared with 30.8% given placebo (odds ratio (OR) 0.29, 95% confidence interval (CI) 0.09 to 0.91). A transient rash was observed in 22.7% of the atropine group compared with 5.1% of the placebo group (OR 5.44, 95% CI 1.11 to 26.6). Vomiting during recovery occurred in 9.1% of atropine patients compared with 25.6% of placebo patients (OR 0.29, 95% CI 0.09 to 1.02). There was a trend towards better tolerance in the placebo group. No patient experienced serious side effects.

conclusionKetamine sedation was successful and well tolerated in all cases. The use of atropine as an adjunct for intramuscular ketamine sedation in children significantly reduces hypersalivation and may lower the incidence of post-procedural vomiting. Atropine is associated with a higher incidence of a transient rash. No serious adverse events were noted.

Indexed as

Adjuvants, AnesthesiaAdolescentAnesthetics, DissociativeAtropineChildChild, PreschoolDouble-Blind MethodDrug CombinationsFemaleHumansInfantInjections, IntramuscularKetamineMaleMinor Surgical ProceduresPainAdjuvants, AnesthesiaAnesthetics, DissociativeAtropineDrug CombinationsKetamine

Identifiers

PMID16498158
PMCPMC2464444
OpenAlexW2063941966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.